ALKBH5 and glioblastoma: These effects could be due to different mRNAs being targeted by ALKBH5 in different cancer cells, for example, FOMX1 in glioblastoma, LYPD1 in hepatocellular carcinoma, PD-L1 in Intrahepatic Cholangiocarcinoma, and so on.18–20 Furthermore, ALKBH5 has also been shown to function as a regulator of miRNA or lncRNA expression to promote tumorigenesis.21 However, at present, the role of ALKBH5 in cervical cancer development remains poorly understood.